{
    "organizations": [],
    "uuid": "9e91ebf0f615ceec813f07c80b21fc6073f28166",
    "author": "",
    "url": "https://www.reuters.com/article/brief-mabvax-therapeutics-says-reverse-s/brief-mabvax-therapeutics-says-reverse-stock-split-is-scheduled-to-be-effective-with-opening-of-trading-on-feb-16-idUSASB0C5XV",
    "ord_in_thread": 0,
    "title": "BRIEF-MabVax Therapeutics Says Reverse Stock Split Is Scheduled To Be Effective With Opening Of Trading On Feb 16",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Market News  43 PM / Updated 12 minutes ago BRIEF-MabVax Therapeutics Says Reverse Stock Split Is Scheduled To Be Effective With Opening Of Trading On Feb 16 Reuters Staff 1 Min Read Feb 15 (Reuters) - MabVax Therapeutics Holdings Inc : * MABVAX THERAPEUTICS SCHEDULES PREVIOUSLY ANNOUNCED 1-FOR-3 REVERSE STOCK SPLIT TO REGAIN COMPLIANCE WITH NASDAQâ€˜S $1.00 MINIMUM BID PRICE MAINTENANCE REQUIREMENT * MABVAX THERAPEUTICS HOLDINGS INC - REVERSE STOCK SPLIT IS SCHEDULED TO BE EFFECTIVE WITH OPENING OF TRADING ON FEB 16, 2018 Source text for Eikon: Further company coverage:",
    "published": "2018-02-15T14:40:00.000+02:00",
    "crawled": "2018-02-15T15:04:06.005+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "market",
        "news",
        "pm",
        "updated",
        "minute",
        "ago",
        "therapeutic",
        "say",
        "reverse",
        "stock",
        "split",
        "scheduled",
        "effective",
        "opening",
        "trading",
        "feb",
        "reuters",
        "staff",
        "min",
        "read",
        "feb",
        "reuters",
        "mabvax",
        "therapeutic",
        "holding",
        "inc",
        "mabvax",
        "therapeutic",
        "schedule",
        "previously",
        "announced",
        "reverse",
        "stock",
        "split",
        "regain",
        "compliance",
        "nasdaq",
        "minimum",
        "bid",
        "price",
        "maintenance",
        "requirement",
        "mabvax",
        "therapeutic",
        "holding",
        "inc",
        "reverse",
        "stock",
        "split",
        "scheduled",
        "effective",
        "opening",
        "trading",
        "feb",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}